Tan et al. (2023) revealed that triggering a receptor expressed on myeloid cells 2 (TREM2)-positive TAMs negatively influenced CD8+ T cells infiltration of HCC after transarterial chemoembolization (TACE), indicating the possible cause of recurrence and HCC progression following TACE [87]. This evidence concerns the gene CD8A and hepatocellular carcinoma.